These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29399341)

  • 1. Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients.
    Ocaña-Mondragón A; Mata-Marín JA; Uriarte-López M; Bekker-Méndez C; Alcalá-Martínez E; Ribas-Aparicio RM; Uribe-Noguéz LA; Rodríguez-Galindo DM; Martínez-Rodríguez ML
    Biomed Rep; 2018 Jan; 8(1):85-90. PubMed ID: 29399341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
    Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M
    Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease.
    Oono T; Yamasaki T; Zaitsu J; Saeki I; Iwamoto T; Harima Y; Marumoto Y; Hidaka I; Urata Y; Ishikawa T; Takami T; Segawa M; Uchida K; Terai S; Kunitugu I; Tanabe T; Sakaida I
    Hepatol Res; 2014 Oct; 44(10):E54-62. PubMed ID: 23905687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
    Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
    J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels.
    Mahendran Y; Jonsson A; Have CT; Allin KH; Witte DR; Jørgensen ME; Grarup N; Pedersen O; Kilpeläinen TO; Hansen T
    Diabetologia; 2017 May; 60(5):873-878. PubMed ID: 28184960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
    Dai CY; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL; Yu ML
    J Hepatol; 2009 Apr; 50(4):712-8. PubMed ID: 19231011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between plasma branched-chain amino acids, β-aminoisobutyric acid and body composition.
    Rietman A; Stanley TL; Clish C; Mootha V; Mensink M; Grinspoon SK; Makimura H
    J Nutr Sci; 2016; 5():e6. PubMed ID: 27313851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.
    Huang JF; Dai CY; Yu ML; Huang CF; Huang CI; Yeh ML; Yang JF; Hou NJ; Hsiao PJ; Lin ZY; Chen SC; Shin SJ; Chuang WL
    Liver Int; 2011 Sep; 31(8):1155-62. PubMed ID: 21745292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients.
    Khattab M; Eslam M; Sharwae MA; Shatat M; Ali A; Hamdy L
    Am J Gastroenterol; 2010 Sep; 105(9):1970-7. PubMed ID: 20234345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart.
    Fillmore N; Wagg CS; Zhang L; Fukushima A; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E1046-E1052. PubMed ID: 30106622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance.
    Yu JW; Sun LJ; Zhao YH; Kang P; Yan BZ
    Int J Infect Dis; 2012 Jun; 16(6):e436-41. PubMed ID: 22486858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a commercially available branched-chain amino acid-alanine-carbohydrate-based sports supplement on perceived exertion and performance in high intensity endurance cycling tests.
    Gervasi M; Sisti D; Amatori S; Donati Zeppa S; Annibalini G; Piccoli G; Vallorani L; Benelli P; Rocchi MBL; Barbieri E; Calavalle AR; Agostini D; Fimognari C; Stocchi V; Sestili P
    J Int Soc Sports Nutr; 2020 Jan; 17(1):6. PubMed ID: 31959202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Niinomi T; Ito T; Hasegawa R; Ando Y; Yamamoto K; Tanaka T
    Hepatol Res; 2014 Mar; 44(3):288-95. PubMed ID: 23607436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.